Monoclonal antibody therapy for COVID-19 during pregnancy

Monoclonal antibody therapy for COVID-19 during pregnancy

Aim. Pregnancy worsens COVID-19 and has been listed by the US Food and Drug Administration as a high risk factor for complicating COVID-19. The severe course of a new coronavirus infection in some pregnant patients has created the prerequisites for the search for treatment methods that can reduce th...

Full description

Bibliographic Details
Main Authors: Diana I. Abdulganieva, Ekaterina V. Dyakova, Era V. Ivanova, Nailya G. Shamsutdinova, Asiya R. Yangurazova, Nigina A. Nigmatullina, Ildar F. Fatkullin
Format: Article
Language:Russian
Published: ZAO "Consilium Medicum" 2023-09-01
Series:Consilium Medicum
Subjects:
covid-19
monoclonal antibodies
sars-cov-2
coronavirus infection
pregnancy
Online Access:https://consilium.orscience.ru/2075-1753/article/viewFile/609534/138174

Internet

https://consilium.orscience.ru/2075-1753/article/viewFile/609534/138174

Similar Items